首页 > 最新文献

Journal of thoracic disease最新文献

英文 中文
Endoscopic thoracic sympathectomy for primary hyperhidrosis: an over a decade-long follow-up on efficacy, impact, and patient satisfaction. 内窥镜胸椎交感神经切除术治疗原发性多汗症:超过十年的疗效、影响和患者满意度随访。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-20 DOI: 10.21037/jtd-24-1407
Néstor J Martínez-Hernández, Míriam Estors-Guerrero, José M Galbis-Caravajal, David Hervás-Marín, Amparo Roig-Bataller

Background: Endoscopic thoracic sympathectomy is a well-known and effective treatment for palmar and axillary primary hyperhidrosis (PHH). Its most frequent drawback and the main complaint among patients who underwent surgery is the appearance of compensatory sweating (CS). To date, no long-term studies using internationally standardized tools have assessed the efficacy and impact of this surgery on patients. In this study we performed a very long-term follow-up of the patients using an internationally validated tool. The aim of this article is to assess the technique as a treatment for hyperhidrosis, focusing on its long-term efficacy, side effects (CS), and patient satisfaction with the procedure.

Methods: A closed cohort study was performed conducting a review of the clinical records to identify 100 consecutive patients who underwent bilateral endoscopic thoracic surgery with a minimum follow-up period of 2 years. Patients with diagnoses other than primary palmar or axillary hyperhidrosis or those for whom follow-up was impossible were excluded. A structured telephone survey, including the International Hyperhidrosis Society "Hyperhidrosis Disease Severity Scale" (HDSS) was conducted for all patients. Data were summarized using median (1st and 3rd quartiles) for quantitative variables and relative and absolute frequencies for qualitative variables. To study the likelihood of a patient recommending the surgery, a Bayesian logistic regression model was used reporting results as odds ratio (OR).

Results: A total of 91 patients were included in the follow-up. The median follow-up duration was 10.66 (5.68, 11.98) years. The most affected zone was the hands (29.67%), and the most common sympathectomy levels were R2 and R3 (68.13%). The overall surgical efficacy rate was of 94.50% and CS appeared in 36.26% of the patients, with 75.76% of these cases being mild and severe in only one patient. In total, 97.8% of patients improved their HDSS score after surgery. The OR of recommending the surgery for a lower HDSS index was 0.24 and 0.18 for the apparition of CS. Despite it, 91.21% of patients recommend the surgery, with an overall satisfaction rate of 93.95%.

Conclusions: Endoscopic thoracic sympathectomy is an effective and safe treatment for palmar and axillary PHH, with a relatively low rate of CS which, when present, is typically mild, making it a highly satisfactory treatment option for patients.

背景:内窥镜胸椎交感神经切除术是一种众所周知的治疗手掌和腋窝原发性多汗症(PHH)的有效方法。其最常见的缺点和主要抱怨患者接受手术是代偿性出汗(CS)的出现。迄今为止,尚无使用国际标准化工具的长期研究评估该手术对患者的疗效和影响。在这项研究中,我们使用国际认可的工具对患者进行了长期随访。本文的目的是评估该技术作为多汗症的治疗方法,重点关注其长期疗效、副作用(CS)和患者对手术的满意度。方法:进行一项封闭队列研究,回顾临床记录,确定100例连续接受双侧内窥镜胸腔镜手术的患者,随访时间至少为2年。排除除原发性掌部或腋窝多汗症以外的诊断或无法随访的患者。对所有患者进行结构化电话调查,包括国际多汗症协会“多汗症严重程度量表”(HDSS)。定量变量采用中位数(第一和第三四分位数),定性变量采用相对和绝对频率。为了研究患者推荐手术的可能性,使用贝叶斯逻辑回归模型将结果报告为优势比(OR)。结果:共纳入91例患者。中位随访时间为10.66(5.68,11.98)年。受影响最大的是手部(29.67%),最常见的交感神经切除水平是R2和R3(68.13%)。手术总有效率为94.50%,CS发生率为36.26%,其中轻、重度仅1例,占75.76%。总的来说,97.8%的患者术后HDSS评分有所改善。HDSS指数较低推荐手术的OR为0.24,CS出现推荐手术的OR为0.18。尽管如此,91.21%的患者推荐手术,总体满意率为93.95%。结论:内窥镜胸椎交感神经切除术是一种有效且安全的治疗掌部和腋窝PHH的方法,CS发生率相对较低,当出现时通常是轻微的,使其成为患者非常满意的治疗选择。
{"title":"Endoscopic thoracic sympathectomy for primary hyperhidrosis: an over a decade-long follow-up on efficacy, impact, and patient satisfaction.","authors":"Néstor J Martínez-Hernández, Míriam Estors-Guerrero, José M Galbis-Caravajal, David Hervás-Marín, Amparo Roig-Bataller","doi":"10.21037/jtd-24-1407","DOIUrl":"https://doi.org/10.21037/jtd-24-1407","url":null,"abstract":"<p><strong>Background: </strong>Endoscopic thoracic sympathectomy is a well-known and effective treatment for palmar and axillary primary hyperhidrosis (PHH). Its most frequent drawback and the main complaint among patients who underwent surgery is the appearance of compensatory sweating (CS). To date, no long-term studies using internationally standardized tools have assessed the efficacy and impact of this surgery on patients. In this study we performed a very long-term follow-up of the patients using an internationally validated tool. The aim of this article is to assess the technique as a treatment for hyperhidrosis, focusing on its long-term efficacy, side effects (CS), and patient satisfaction with the procedure.</p><p><strong>Methods: </strong>A closed cohort study was performed conducting a review of the clinical records to identify 100 consecutive patients who underwent bilateral endoscopic thoracic surgery with a minimum follow-up period of 2 years. Patients with diagnoses other than primary palmar or axillary hyperhidrosis or those for whom follow-up was impossible were excluded. A structured telephone survey, including the International Hyperhidrosis Society \"Hyperhidrosis Disease Severity Scale\" (HDSS) was conducted for all patients. Data were summarized using median (1<sup>st</sup> and 3<sup>rd</sup> quartiles) for quantitative variables and relative and absolute frequencies for qualitative variables. To study the likelihood of a patient recommending the surgery, a Bayesian logistic regression model was used reporting results as odds ratio (OR).</p><p><strong>Results: </strong>A total of 91 patients were included in the follow-up. The median follow-up duration was 10.66 (5.68, 11.98) years. The most affected zone was the hands (29.67%), and the most common sympathectomy levels were R2 and R3 (68.13%). The overall surgical efficacy rate was of 94.50% and CS appeared in 36.26% of the patients, with 75.76% of these cases being mild and severe in only one patient. In total, 97.8% of patients improved their HDSS score after surgery. The OR of recommending the surgery for a lower HDSS index was 0.24 and 0.18 for the apparition of CS. Despite it, 91.21% of patients recommend the surgery, with an overall satisfaction rate of 93.95%.</p><p><strong>Conclusions: </strong>Endoscopic thoracic sympathectomy is an effective and safe treatment for palmar and axillary PHH, with a relatively low rate of CS which, when present, is typically mild, making it a highly satisfactory treatment option for patients.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8292-8299"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A two-sample mendelian randomization study of non-tuberculous mycobacteria infection and lung cancer. 非结核分枝杆菌感染与肺癌的两样本孟德尔随机化研究。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-12 DOI: 10.21037/jtd-24-1268
Hao Shen, Mingjun Yang

Background: Non-tuberculous mycobacterial lung disease may coexist or precede lung cancer, yet a causal link remains unproven. This study aimed to elucidate the causal association between non-tuberculous mycobacteria (NTM) and lung cancer.

Methods: Summary data from genome-wide association studies (GWAS) for NTM, atypical mycobacterial lung infections, and various types of lung cancer were utilized. A two-sample Mendelian randomization (MR) design was applied using the inverse variance weighted (IVW), weighted median, weighted mode, and MR-Egger regression methods. Sensitivity analysis and MR Pleiotropy RESidual Sum and Outlier (MR-PRESSO) were used to detect and correct for horizontal pleiotropy. The leave-one-out analysis was used to evaluate the robustness of the results.

Results: The IVW results showed no significant causal relationships between NTM infection and the risk of lung cancer and between atypical mycobacterial lung infection and the risk of lung cancer. The results of the weighted median, weighted mode, and MR-Egger regression methods aligned with those of the IVW method. Cochran's Q test revealed that heterogeneity significantly influenced the association between NTM pulmonary infections and lung cancer. The MR-PRESSO analysis identified two outlier instrumental variables (IVs); after excluding them, the results remained similar, without causal associations.

Conclusions: The findings of this study do not support a genetically causal relationship between NTM and atypical mycobacterial lung infections with lung cancer.

背景:非结核性分枝杆菌肺病可能共存或发生于肺癌,但其因果关系尚未得到证实。本研究旨在阐明非结核分枝杆菌(NTM)与肺癌的因果关系。方法:利用NTM、非典型分枝杆菌肺部感染和各种类型肺癌的全基因组关联研究(GWAS)的汇总数据。采用双样本孟德尔随机化(MR)设计,采用反方差加权(IVW)、加权中位数、加权模式和MR- egger回归方法。采用敏感性分析和MR多效性残差和离群值(MR- presso)检测和校正水平多效性。采用留一分析来评价结果的稳健性。结果:IVW结果显示NTM感染与肺癌风险、非典型分枝杆菌感染与肺癌风险无显著因果关系。加权中位数、加权模式和MR-Egger回归方法的结果与IVW方法的结果一致。Cochran’s Q检验显示,异质性显著影响NTM肺部感染与肺癌之间的关系。MR-PRESSO分析确定了两个异常的工具变量(IVs);排除这些因素后,结果仍然相似,没有因果关系。结论:本研究结果不支持NTM与非典型分枝杆菌肺部感染与肺癌之间的遗传因果关系。
{"title":"A two-sample mendelian randomization study of non-tuberculous mycobacteria infection and lung cancer.","authors":"Hao Shen, Mingjun Yang","doi":"10.21037/jtd-24-1268","DOIUrl":"https://doi.org/10.21037/jtd-24-1268","url":null,"abstract":"<p><strong>Background: </strong>Non-tuberculous mycobacterial lung disease may coexist or precede lung cancer, yet a causal link remains unproven. This study aimed to elucidate the causal association between non-tuberculous mycobacteria (NTM) and lung cancer.</p><p><strong>Methods: </strong>Summary data from genome-wide association studies (GWAS) for NTM, atypical mycobacterial lung infections, and various types of lung cancer were utilized. A two-sample Mendelian randomization (MR) design was applied using the inverse variance weighted (IVW), weighted median, weighted mode, and MR-Egger regression methods. Sensitivity analysis and MR Pleiotropy RESidual Sum and Outlier (MR-PRESSO) were used to detect and correct for horizontal pleiotropy. The leave-one-out analysis was used to evaluate the robustness of the results.</p><p><strong>Results: </strong>The IVW results showed no significant causal relationships between NTM infection and the risk of lung cancer and between atypical mycobacterial lung infection and the risk of lung cancer. The results of the weighted median, weighted mode, and MR-Egger regression methods aligned with those of the IVW method. Cochran's <i>Q</i> test revealed that heterogeneity significantly influenced the association between NTM pulmonary infections and lung cancer. The MR-PRESSO analysis identified two outlier instrumental variables (IVs); after excluding them, the results remained similar, without causal associations.</p><p><strong>Conclusions: </strong>The findings of this study do not support a genetically causal relationship between NTM and atypical mycobacterial lung infections with lung cancer.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8472-8481"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serious mental illness prolongs hospital admission following lung cancer resection. 严重的精神疾病延长了肺癌切除术后的住院时间。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-28 DOI: 10.21037/jtd-24-762
J Nathaniel Diehl, Audrey L Khoury, Julia A Brickey, Adam M Awe, Chris B Agala, Gita N Mody, Benjamin E Haithcock, Jonathan S Gerkin, Jason M Long

Background: Serious mental illness (SMI) is associated with increased complications and worse outcomes in a variety of surgical diseases, however, SMI as a risk factor in thoracic surgery patients is incompletely understood. We aimed to investigate if comorbid SMI would impact mortality and morbidity following lung cancer resection.

Methods: We identified 615 patients from the Society of Thoracic Surgery (STS) database at the University of North Carolina - Chapel Hill (January 2013-June 2021) who underwent lung cancer resection for non-small cell lung cancer (NSCLC). Patients identified with comorbid SMI as defined in prior studies were identified and stratified into mood, anxiety, and psychosis disorders. We analyzed the risk-adjusted impact of SMI on composite morbidity and mortality and length of stay (LOS) using multivariable logistic regression and Poisson regression analysis, respectively.

Results: Patients with SMI were younger, more frequently female, and more likely to be a smoker. Among identified patients, 186 (37.1%) had comorbid SMI which were predominantly mood disorders (90.3%). Overall, 116 patients (23.2%) had the primary outcome of composite postoperative mortality or morbidity. Following multivariable risk adjustment, patients with and without SMI did not have significantly different morbidity and mortality [odds ratio (OR) =1.36; 95% confidence interval (CI): 0.86-2.15]. After adjusting for surgery performed and other covariates, LOS was significantly longer among patients with SMI [risk ratio (RR) =1.21; 95% CI: 1.13-1.30].

Conclusions: In a 7.5-year period from a single academic institution, patients undergoing lung cancer resection had high rates of SMI. While no difference in composite morbidity and mortality was demonstrated, patients with SMI had significantly longer LOS.

背景:严重精神疾病(SMI)与各种外科疾病的并发症增加和预后不良相关,然而,SMI作为胸外科患者的危险因素尚不完全清楚。我们的目的是调查合并症重度精神损伤是否会影响肺癌切除术后的死亡率和发病率。方法:我们从北卡罗来纳大学教堂山分校胸外科学会(STS)数据库(2013年1月- 2021年6月)中确定了615例因非小细胞肺癌(NSCLC)接受肺癌切除术的患者。在先前的研究中被确定为共病性重度精神分裂症的患者被确定并分为情绪障碍、焦虑障碍和精神障碍。我们分别使用多变量logistic回归和泊松回归分析分析了SMI对综合发病率、死亡率和住院时间(LOS)的风险调整影响。结果:重度精神分裂症患者较年轻,多为女性,更有可能是吸烟者。在确诊的患者中,186例(37.1%)患有重度精神分裂症共病,其中以情绪障碍为主(90.3%)。总体而言,116例患者(23.2%)的主要结局为复合术后死亡率或发病率。多变量风险调整后,重度精神分裂症患者和非重度精神分裂症患者的发病率和死亡率没有显著差异[优势比(OR) =1.36;95%置信区间(CI): 0.86-2.15]。在调整手术和其他协变量后,重度精神分裂症患者的LOS明显更长[风险比(RR) =1.21;95% ci: 1.13-1.30]。结论:在一个学术机构的7.5年时间里,接受肺癌切除术的患者有很高的SMI发生率。虽然复合发病率和死亡率没有差异,但重度精神分裂症患者的LOS明显更长。
{"title":"Serious mental illness prolongs hospital admission following lung cancer resection.","authors":"J Nathaniel Diehl, Audrey L Khoury, Julia A Brickey, Adam M Awe, Chris B Agala, Gita N Mody, Benjamin E Haithcock, Jonathan S Gerkin, Jason M Long","doi":"10.21037/jtd-24-762","DOIUrl":"https://doi.org/10.21037/jtd-24-762","url":null,"abstract":"<p><strong>Background: </strong>Serious mental illness (SMI) is associated with increased complications and worse outcomes in a variety of surgical diseases, however, SMI as a risk factor in thoracic surgery patients is incompletely understood. We aimed to investigate if comorbid SMI would impact mortality and morbidity following lung cancer resection.</p><p><strong>Methods: </strong>We identified 615 patients from the Society of Thoracic Surgery (STS) database at the University of North Carolina - Chapel Hill (January 2013-June 2021) who underwent lung cancer resection for non-small cell lung cancer (NSCLC). Patients identified with comorbid SMI as defined in prior studies were identified and stratified into mood, anxiety, and psychosis disorders. We analyzed the risk-adjusted impact of SMI on composite morbidity and mortality and length of stay (LOS) using multivariable logistic regression and Poisson regression analysis, respectively.</p><p><strong>Results: </strong>Patients with SMI were younger, more frequently female, and more likely to be a smoker. Among identified patients, 186 (37.1%) had comorbid SMI which were predominantly mood disorders (90.3%). Overall, 116 patients (23.2%) had the primary outcome of composite postoperative mortality or morbidity. Following multivariable risk adjustment, patients with and without SMI did not have significantly different morbidity and mortality [odds ratio (OR) =1.36; 95% confidence interval (CI): 0.86-2.15]. After adjusting for surgery performed and other covariates, LOS was significantly longer among patients with SMI [risk ratio (RR) =1.21; 95% CI: 1.13-1.30].</p><p><strong>Conclusions: </strong>In a 7.5-year period from a single academic institution, patients undergoing lung cancer resection had high rates of SMI. While no difference in composite morbidity and mortality was demonstrated, patients with SMI had significantly longer LOS.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8450-8460"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uniportal video-assisted thoracic surgery resection of subsolid or millimetric nodules using an innovative micro-coil technique: our experience. 利用创新的微线圈技术进行单门静脉视频辅助胸外科手术切除亚实性或毫米结节:我们的经验。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-18 DOI: 10.21037/jtd-24-628
Maria Teresa Congedo, Andrea Contegiacomo, Dania Nachira, Marco Chiappetta, Giuseppe Calabrese, Marcello Lippi, Alessandro Cina, Filippo Lococo, Elisa Meacci, Maria Letizia Vita, Leonardo Petracca Ciavarella, Stefano Margaritora, Roberto Iezzi

Background: Sometimes, the identification of ground-glass opacities (GGOs), small or deep pulmonary nodules can be difficult also in expert hands. Usually for these lesions pulmonary lobectomy is an overtreatment, so we developed a technique to identify easily these nodules. The objective of this research is to assess the effectiveness and safety of using preoperative cone beam computed tomography (CBCT) to guide the placement of micro-coils in the lung parenchyma near GGO and small lesions. Additionally, the study aims to identify potential factors that could predict coil-assisted failures during uniportal video-assisted thoracic surgery (U-VATS) resections.

Methods: The clinical, radiological, and surgical records of 117 patients who underwent U-VATS resection following CBCT-guided micro-coil localization of GGOs and small deep nodules between January 2017 and February 2023 were retrospectively analyzed. We have placed a micro coil under CBCT guide before the intervention in the 24 hours preceding the intervention. The patient received a pulmonary wedge resection in U-VATS technique and an immediate fresh frozen section to determine the necessity of a pulmonary lobectomy.

Results: One hundred and eight lesions/117 lesions (92.3%) were correctly identified by the coil. The coil placement had only mild complications: perilesional bleeding, pneumothorax requiring pleural drainage (2/117), hypotension (2/117), subcutaneous emphysema (1/117) and 1 case of coil retained in the chest wall. Ninety-seven lesions/117 lesions (82.9%) were malignant. Among these, 74 (76.3%) were lung adenocarcinomas.

Conclusions: Preoperative CBCT-guided micro-coil localization, is a safe and cheap procedure, allows the detection of GGOs, small or deep nodules in U-VATS with low rate of conversion to thoracotomy and few complications, without any use of intraoperatory radiations.

背景:有时,在专家的指导下,毛玻璃混浊(GGOs)、小或深肺结节的识别也很困难。通常对于这些病变,肺叶切除术是一种过度治疗,因此我们开发了一种技术来轻松识别这些结节。本研究的目的是评估术前使用锥形束计算机断层扫描(CBCT)在靠近GGO和小病变的肺实质中引导微线圈放置的有效性和安全性。此外,该研究的目的是确定在单门静脉胸外科手术(U-VATS)切除术中可能预测线圈辅助失败的潜在因素。方法:回顾性分析2017年1月至2023年2月117例cbct引导下微线圈定位GGOs和小深部结节后行U-VATS切除术的患者的临床、影像学和手术记录。在干预前24小时,我们在CBCT引导下放置了一个微线圈。患者接受U-VATS技术的肺楔形切除术和立即新鲜冷冻切片以确定肺叶切除术的必要性。结果:117个病变中有108个病变被线圈正确识别,准确率为92.3%。线圈置入仅出现轻微并发症:病灶周围出血、气胸需要胸腔引流(2/117)、低血压(2/117)、皮下肺气肿(1/117)和1例线圈滞留在胸壁。117个病变中97个为恶性,占82.9%。其中74例(76.3%)为肺腺癌。结论:术前cbct引导下的微线圈定位是一种安全、廉价的方法,可以检测到ggo, U-VATS中的小结节或深部结节,转开胸率低,并发症少,无需术中放疗。
{"title":"Uniportal video-assisted thoracic surgery resection of subsolid or millimetric nodules using an innovative micro-coil technique: our experience.","authors":"Maria Teresa Congedo, Andrea Contegiacomo, Dania Nachira, Marco Chiappetta, Giuseppe Calabrese, Marcello Lippi, Alessandro Cina, Filippo Lococo, Elisa Meacci, Maria Letizia Vita, Leonardo Petracca Ciavarella, Stefano Margaritora, Roberto Iezzi","doi":"10.21037/jtd-24-628","DOIUrl":"https://doi.org/10.21037/jtd-24-628","url":null,"abstract":"<p><strong>Background: </strong>Sometimes, the identification of ground-glass opacities (GGOs), small or deep pulmonary nodules can be difficult also in expert hands. Usually for these lesions pulmonary lobectomy is an overtreatment, so we developed a technique to identify easily these nodules. The objective of this research is to assess the effectiveness and safety of using preoperative cone beam computed tomography (CBCT) to guide the placement of micro-coils in the lung parenchyma near GGO and small lesions. Additionally, the study aims to identify potential factors that could predict coil-assisted failures during uniportal video-assisted thoracic surgery (U-VATS) resections.</p><p><strong>Methods: </strong>The clinical, radiological, and surgical records of 117 patients who underwent U-VATS resection following CBCT-guided micro-coil localization of GGOs and small deep nodules between January 2017 and February 2023 were retrospectively analyzed. We have placed a micro coil under CBCT guide before the intervention in the 24 hours preceding the intervention. The patient received a pulmonary wedge resection in U-VATS technique and an immediate fresh frozen section to determine the necessity of a pulmonary lobectomy.</p><p><strong>Results: </strong>One hundred and eight lesions/117 lesions (92.3%) were correctly identified by the coil. The coil placement had only mild complications: perilesional bleeding, pneumothorax requiring pleural drainage (2/117), hypotension (2/117), subcutaneous emphysema (1/117) and 1 case of coil retained in the chest wall. Ninety-seven lesions/117 lesions (82.9%) were malignant. Among these, 74 (76.3%) were lung adenocarcinomas.</p><p><strong>Conclusions: </strong>Preoperative CBCT-guided micro-coil localization, is a safe and cheap procedure, allows the detection of GGOs, small or deep nodules in U-VATS with low rate of conversion to thoracotomy and few complications, without any use of intraoperatory radiations.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8424-8434"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740051/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulatory mechanisms of haptoglobin on particulate matter-induced epithelial-to-mesenchymal transition in bronchial epithelial cells. 接触珠蛋白对颗粒物质诱导支气管上皮细胞向间质转化的调控机制。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-28 DOI: 10.21037/jtd-2024-2013
Yao Qian, Chenchen Fang, Beibei Wang, Zhixiao Xu, Wenkai Yu, Andrei I Gritsiuta, Chengshui Chen, Nian Dong, Junjie Chen

Background: It has been proposed that repeated exposure of bronchial epithelial cells to atmospheric particulate matter (PM) could disrupt airway epithelial integrity and lead to epithelial-to-mesenchymal transition (EMT) and ultimately airway remodeling. The molecular mechanisms underlying PM-related bronchial epithelial EMT have not yet been elucidated. The aim of this research is to clarify the molecular mechanism of EMT upon PM exposure.

Methods: Using an in vivo mouse model of PM-induced airway inflammation and an in vitro model of PM-stimulated bronchial epithelial cells, we clarified the role of haptoglobin (HP) in PM-induced bronchial epithelial EMT. The expression of HP in lung tissues was evaluated by immunohistochemistry (IHC). Western blotting (WB) and immunofluorescence staining were used to analyze EMT-related protein expression and the relevant signaling pathways in the changes in lung tissues and bronchial epithelial cells upon PM exposure. HP small interfering RNA (siRNA) was used to implement the interference of endogenous HP.

Results: In vivo experiments showed elevated HP expression in the bronchial epithelium upon PM exposure. IHC and WB showed that E-cadherin expression was decreased, and vimentin expression was increased in bronchial epithelial cells. Moreover, WB results showed that the phosphorylation levels of signal transducer and activator of transcription 3 (STAT3) and extracellular regulated protein kinases (ERK) were elevated in the lung parenchymal tissue of mice. The results of in vitro molecular mechanism experiments showed that compared with those of the control group, the phosphorylation levels of STAT3 and ERK in the PM group increased progressively with higher concentrations of PM and longer stimulation durations. BEAS-2B cells were pretreated with stattic (STAT3 inhibitor) and/or U0126 (ERK inhibitor), and it was found that either stattic or U0126 inhibited PM-induced reduction of E-cadherin expression and elevation of vimentin expression, and the inhibitory effect was most significant when both inhibitors were pretreated simultaneously. Through transfection of BEAS-2B cells with HP siRNA, WB results showed that HP siRNA partially reversed the PM-induced reduction in E-cadherin expression and elevation of vimentin expression, in addition to the reduction in the phosphorylation levels of the STAT3 and ERK.

Conclusions: HP is an important mediator of PM-induced EMT in bronchial epithelial cells and promotes PM-induced EMT in bronchial epithelial cells through activation of the STAT3 signaling pathway and the ERK signaling pathway. Inhibition of HP expression attenuates PM exposure-induced EMT in bronchial epithelial cells.

背景:有研究认为,支气管上皮细胞反复暴露于大气颗粒物(PM)会破坏气道上皮的完整性,导致上皮向间质转化(EMT),最终导致气道重塑。pm相关支气管上皮EMT的分子机制尚未阐明。本研究的目的是阐明PM暴露后EMT的分子机制。方法:采用pm诱导的小鼠气道炎症模型和pm刺激的支气管上皮细胞体外模型,明确了触珠蛋白(haptoglobin, HP)在pm诱导的支气管上皮EMT中的作用。采用免疫组化(IHC)方法检测肺组织中HP的表达。应用Western blotting (WB)和免疫荧光染色分析PM暴露后肺组织和支气管上皮细胞中emt相关蛋白的表达及相关信号通路的变化。采用HP小干扰RNA (siRNA)对内源性HP进行干扰。结果:体内实验显示PM暴露后支气管上皮HP表达升高。IHC和WB显示支气管上皮细胞E-cadherin表达降低,vimentin表达升高。WB结果显示,小鼠肺实质组织中信号传导和转录激活因子3 (STAT3)和细胞外调节蛋白激酶(ERK)的磷酸化水平升高。体外分子机制实验结果显示,与对照组相比,PM组STAT3和ERK的磷酸化水平随着PM浓度的升高和刺激时间的延长而逐渐升高。用STAT3抑制剂statstatic和/或U0126 (ERK抑制剂)预处理BEAS-2B细胞,发现statstatic和U0126均能抑制pm诱导的E-cadherin表达降低和vimentin表达升高,且两种抑制剂同时预处理时抑制效果最显著。用HP siRNA转染BEAS-2B细胞,WB结果显示HP siRNA部分逆转了pm诱导的E-cadherin表达降低和vimentin表达升高,以及STAT3和ERK磷酸化水平的降低。结论:HP是pm诱导支气管上皮细胞EMT的重要介质,通过激活STAT3信号通路和ERK信号通路促进pm诱导支气管上皮细胞EMT。抑制HP表达可减弱PM暴露诱导的支气管上皮细胞EMT。
{"title":"Regulatory mechanisms of haptoglobin on particulate matter-induced epithelial-to-mesenchymal transition in bronchial epithelial cells.","authors":"Yao Qian, Chenchen Fang, Beibei Wang, Zhixiao Xu, Wenkai Yu, Andrei I Gritsiuta, Chengshui Chen, Nian Dong, Junjie Chen","doi":"10.21037/jtd-2024-2013","DOIUrl":"https://doi.org/10.21037/jtd-2024-2013","url":null,"abstract":"<p><strong>Background: </strong>It has been proposed that repeated exposure of bronchial epithelial cells to atmospheric particulate matter (PM) could disrupt airway epithelial integrity and lead to epithelial-to-mesenchymal transition (EMT) and ultimately airway remodeling. The molecular mechanisms underlying PM-related bronchial epithelial EMT have not yet been elucidated. The aim of this research is to clarify the molecular mechanism of EMT upon PM exposure.</p><p><strong>Methods: </strong>Using an <i>in vivo</i> mouse model of PM-induced airway inflammation and an <i>in vitro</i> model of PM-stimulated bronchial epithelial cells, we clarified the role of haptoglobin (HP) in PM-induced bronchial epithelial EMT. The expression of HP in lung tissues was evaluated by immunohistochemistry (IHC). Western blotting (WB) and immunofluorescence staining were used to analyze EMT-related protein expression and the relevant signaling pathways in the changes in lung tissues and bronchial epithelial cells upon PM exposure. HP small interfering RNA (siRNA) was used to implement the interference of endogenous HP.</p><p><strong>Results: </strong><i>In vivo</i> experiments showed elevated HP expression in the bronchial epithelium upon PM exposure. IHC and WB showed that E-cadherin expression was decreased, and vimentin expression was increased in bronchial epithelial cells. Moreover, WB results showed that the phosphorylation levels of signal transducer and activator of transcription 3 (STAT3) and extracellular regulated protein kinases (ERK) were elevated in the lung parenchymal tissue of mice. The results of <i>in vitro</i> molecular mechanism experiments showed that compared with those of the control group, the phosphorylation levels of STAT3 and ERK in the PM group increased progressively with higher concentrations of PM and longer stimulation durations. BEAS-2B cells were pretreated with stattic (STAT3 inhibitor) and/or U0126 (ERK inhibitor), and it was found that either stattic or U0126 inhibited PM-induced reduction of E-cadherin expression and elevation of vimentin expression, and the inhibitory effect was most significant when both inhibitors were pretreated simultaneously. Through transfection of BEAS-2B cells with HP siRNA, WB results showed that HP siRNA partially reversed the PM-induced reduction in E-cadherin expression and elevation of vimentin expression, in addition to the reduction in the phosphorylation levels of the STAT3 and ERK.</p><p><strong>Conclusions: </strong>HP is an important mediator of PM-induced EMT in bronchial epithelial cells and promotes PM-induced EMT in bronchial epithelial cells through activation of the STAT3 signaling pathway and the ERK signaling pathway. Inhibition of HP expression attenuates PM exposure-induced EMT in bronchial epithelial cells.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8724-8742"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic fiberoptic bronchoscopy after sleeve lobectomy can reduce the incidence of postoperative pneumonia: a propensity score matching study. 袖状肺叶切除术后预防性纤维支气管镜检查可降低术后肺炎的发生率:倾向评分匹配研究。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-16 DOI: 10.21037/jtd-24-1326
Jie Cao, Zhiyu Peng, Huahang Lin, Zhaokang Huang, Zetao Liu, Qiang Pu, Lunxu Liu, Chenglin Guo, Jiandong Mei

Background: Postoperative pneumonia (POP) predicts poor outcomes after lung surgery, especially for patients undergoing sleeve lobectomy. Fiberoptic bronchoscopy (FOB) is frequently used in the treatment of POP for patients receiving sleeve lobectomy. This study aimed to assess the effect of prophylactic FOB on the incidence of POP in these patients.

Methods: This is a single-center retrospective cohort study. Postoperative outcomes of patients who underwent sleeve lobectomy for central lung cancer from August 2005 to August 2020 in the West China Hospital were collected. The included patients were divided into two groups based on whether prophylactic FOB was performed, and the two groups were compared using propensity score matching (PSM).

Results: A total of 314 patients were included in this study. There were 166 patients in the aspirated group and 148 patients in the non-aspirated group. PSM resulted in 133 patients in each group. The aspirated group was associated with a lower incidence of POP (7.5% vs. 17.3%; P=0.03), shorter duration of antibiotic use (5.6±3.3 vs. 6.9±3.9 days; P=0.003), and shorter postoperative hospital stay (9.3±4.8 vs. 10.7±5.5 days; P=0.04).

Conclusions: Prophylactic FOB after sleeve lobectomy was associated with improved postoperative outcomes and might be recommended for patients undergoing sleeve lobectomy.

背景:术后肺炎(POP)预示着肺部手术后的不良预后,尤其是对接受袖状肺叶切除术的患者。纤维支气管镜检查(FOB)常用于接受袖状肺叶切除术的患者的POP治疗。本研究旨在评估预防性FOB对这些患者发生POP的影响。方法:这是一项单中心回顾性队列研究。收集2005年8月至2020年8月华西医院行中心性肺癌套筒肺叶切除术患者的术后结果。将纳入的患者根据是否进行预防性离岸性治疗分为两组,采用倾向评分匹配(PSM)对两组患者进行比较。结果:本研究共纳入314例患者。有吸气组166例,无吸气组148例。两组共133例PSM患者。吸入组与较低的POP发生率相关(7.5% vs. 17.3%;P=0.03),抗生素使用时间较短(5.6±3.3 vs. 6.9±3.9天;P=0.003),术后住院时间较短(9.3±4.8天vs. 10.7±5.5天;P = 0.04)。结论:套筒肺叶切除术后预防性肺外通气可改善术后预后,可推荐用于套筒肺叶切除术患者。
{"title":"Prophylactic fiberoptic bronchoscopy after sleeve lobectomy can reduce the incidence of postoperative pneumonia: a propensity score matching study.","authors":"Jie Cao, Zhiyu Peng, Huahang Lin, Zhaokang Huang, Zetao Liu, Qiang Pu, Lunxu Liu, Chenglin Guo, Jiandong Mei","doi":"10.21037/jtd-24-1326","DOIUrl":"https://doi.org/10.21037/jtd-24-1326","url":null,"abstract":"<p><strong>Background: </strong>Postoperative pneumonia (POP) predicts poor outcomes after lung surgery, especially for patients undergoing sleeve lobectomy. Fiberoptic bronchoscopy (FOB) is frequently used in the treatment of POP for patients receiving sleeve lobectomy. This study aimed to assess the effect of prophylactic FOB on the incidence of POP in these patients.</p><p><strong>Methods: </strong>This is a single-center retrospective cohort study. Postoperative outcomes of patients who underwent sleeve lobectomy for central lung cancer from August 2005 to August 2020 in the West China Hospital were collected. The included patients were divided into two groups based on whether prophylactic FOB was performed, and the two groups were compared using propensity score matching (PSM).</p><p><strong>Results: </strong>A total of 314 patients were included in this study. There were 166 patients in the aspirated group and 148 patients in the non-aspirated group. PSM resulted in 133 patients in each group. The aspirated group was associated with a lower incidence of POP (7.5% <i>vs.</i> 17.3%; P=0.03), shorter duration of antibiotic use (5.6±3.3 <i>vs.</i> 6.9±3.9 days; P=0.003), and shorter postoperative hospital stay (9.3±4.8 <i>vs.</i> 10.7±5.5 days; P=0.04).</p><p><strong>Conclusions: </strong>Prophylactic FOB after sleeve lobectomy was associated with improved postoperative outcomes and might be recommended for patients undergoing sleeve lobectomy.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8503-8512"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of serum biomarkers and therapeutic targets for aortic diseases in obesity through multi-omics analysis. 通过多组学分析鉴定肥胖主动脉疾病的血清生物标志物和治疗靶点。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-28 DOI: 10.21037/jtd-24-1113
Tianren Wang, Yuhang Wang, Yansong Wang, Xiaokang Wang, Xinyu Cheng, Qiwen Tan, Tiancheng Zhu, Xiaomei Teng, Haoyue Huang, Zhenya Shen

Background: Obesity is associated with an increased risk of aortic diseases and operative risks. Currently, there are no effective drugs available to prevent the occurrence and progression of aortic aneurysms or dissections. We investigated potential biomarkers and therapeutic targets using a multi-omics approach.

Methods: Clinical data from 237 patients with aortic disease were analyzed based on body mass index (BMI) to explore the relationship between BMI and clinical outcomes. An obesity mouse model was developed by feeding a high fat diet (HFD), and an aortic disease model was established by administering human angiotensin II (AngII) at a dosage of 1,000 ng/min/kg via osmotic minipumps. Through analysis of murine aortic transcriptomics and serum proteomics, we identified potential biomarkers for aortic disease with obesity. Enzyme-linked immunosorbent assay was used to detect these biomarkers in human serum.

Results: This study analyzed a cohort of 237 patients with aortic disease and 72 patients with valvulopathy. Patients with aortic disease exhibited a significantly higher BMI and a lower mean age compared to those with valvulopathy. Among the aortic disease group, elevated BMI was associated with a younger age, increased systolic and diastolic blood pressure, and a higher percentage of neutrophils. Transcriptomic analysis revealed an enrichment of genes related to complement and coagulation cascades, as well as the prion disease pathway. Proteomic analysis showed an enrichment of proteins associated with African trypanosomiasis and the estrogen signaling pathway. By integrating transcriptomic and proteomic profiles, complement component 5 (C5) and apolipoprotein D (apoD) were identified as potential biomarkers for the adverse effects of obesity.

Conclusions: High BMI is associated with an increased risk of aortic disease, particularly aortic dissection. Serum C5 and apoD have been identified as potential biomarkers for evaluating the risk of aortic disease in obese individuals. Further research is necessary to explore the pathophysiological pathways correlated with these biomarkers and their potential clinical applications.

背景:肥胖与主动脉疾病和手术风险增加有关。目前,还没有有效的药物可以预防主动脉瘤或夹层的发生和发展。我们使用多组学方法研究了潜在的生物标志物和治疗靶点。方法:对237例主动脉病变患者的临床资料进行基于体重指数(BMI)的分析,探讨BMI与临床预后的关系。通过高脂饮食(HFD)建立肥胖小鼠模型,通过渗透微型泵给药1000 ng/min/kg的人血管紧张素II (AngII)建立主动脉疾病模型。通过分析小鼠主动脉转录组学和血清蛋白质组学,我们确定了肥胖主动脉疾病的潜在生物标志物。采用酶联免疫吸附法检测人血清中的这些生物标志物。结果:本研究分析了237例主动脉疾病患者和72例瓣膜病变患者。与瓣膜病变患者相比,主动脉疾病患者表现出明显更高的BMI和更低的平均年龄。在主动脉疾病组中,BMI升高与年龄更年轻、收缩压和舒张压升高以及中性粒细胞比例更高有关。转录组学分析显示,与补体和凝血级联以及朊病毒疾病途径相关的基因富集。蛋白质组学分析显示与非洲锥虫病和雌激素信号通路相关的蛋白质富集。通过整合转录组学和蛋白质组学,补体组分5 (C5)和载脂蛋白D (apoD)被确定为肥胖不良反应的潜在生物标志物。结论:高BMI与主动脉疾病的风险增加有关,尤其是主动脉夹层。血清C5和apoD已被确定为评估肥胖个体主动脉疾病风险的潜在生物标志物。进一步的研究需要探索与这些生物标志物相关的病理生理途径及其潜在的临床应用。
{"title":"Identification of serum biomarkers and therapeutic targets for aortic diseases in obesity through multi-omics analysis.","authors":"Tianren Wang, Yuhang Wang, Yansong Wang, Xiaokang Wang, Xinyu Cheng, Qiwen Tan, Tiancheng Zhu, Xiaomei Teng, Haoyue Huang, Zhenya Shen","doi":"10.21037/jtd-24-1113","DOIUrl":"https://doi.org/10.21037/jtd-24-1113","url":null,"abstract":"<p><strong>Background: </strong>Obesity is associated with an increased risk of aortic diseases and operative risks. Currently, there are no effective drugs available to prevent the occurrence and progression of aortic aneurysms or dissections. We investigated potential biomarkers and therapeutic targets using a multi-omics approach.</p><p><strong>Methods: </strong>Clinical data from 237 patients with aortic disease were analyzed based on body mass index (BMI) to explore the relationship between BMI and clinical outcomes. An obesity mouse model was developed by feeding a high fat diet (HFD), and an aortic disease model was established by administering human angiotensin II (AngII) at a dosage of 1,000 ng/min/kg via osmotic minipumps. Through analysis of murine aortic transcriptomics and serum proteomics, we identified potential biomarkers for aortic disease with obesity. Enzyme-linked immunosorbent assay was used to detect these biomarkers in human serum.</p><p><strong>Results: </strong>This study analyzed a cohort of 237 patients with aortic disease and 72 patients with valvulopathy. Patients with aortic disease exhibited a significantly higher BMI and a lower mean age compared to those with valvulopathy. Among the aortic disease group, elevated BMI was associated with a younger age, increased systolic and diastolic blood pressure, and a higher percentage of neutrophils. Transcriptomic analysis revealed an enrichment of genes related to complement and coagulation cascades, as well as the prion disease pathway. Proteomic analysis showed an enrichment of proteins associated with African trypanosomiasis and the estrogen signaling pathway. By integrating transcriptomic and proteomic profiles, complement component 5 (C5) and apolipoprotein D (apoD) were identified as potential biomarkers for the adverse effects of obesity.</p><p><strong>Conclusions: </strong>High BMI is associated with an increased risk of aortic disease, particularly aortic dissection. Serum C5 and apoD have been identified as potential biomarkers for evaluating the risk of aortic disease in obese individuals. Further research is necessary to explore the pathophysiological pathways correlated with these biomarkers and their potential clinical applications.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8435-8449"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of antifibrotic therapy on lung cancer incidence and mortality in patients with idiopathic pulmonary fibrosis. 抗纤维化治疗对特发性肺纤维化患者肺癌发病率和死亡率的影响。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-28 DOI: 10.21037/jtd-24-1356
Yong Suk Jo, Kyung Joo Kim, Chin Kook Rhee, Yong Hyun Kim

Background: Patients with idiopathic pulmonary fibrosis (IPF) are at risk of lung cancer development. Antifibrotic therapy could slow disease progression of IPF, but there is limited data on its effectiveness on lung cancer. Here, we aimed to investigate lung cancer incidence and the risk of mortality of patients with IPF receiving antifibrotic therapy.

Methods: Data from the Korean National Health Insurance service database between October 2015 and September 2021 were used. The incidence of lung cancer and all-cause mortality in the IPF cohort was analyzed depending on pirfenidone treatment. Those who were diagnosed with lung cancer prior to IPF diagnosis were excluded.

Results: Among the 5,038 patients with IPF who were eligible for the study, pirfenidone was administered to 880 patients. Median follow-up duration was 4,872.8 and 23,612.1 person-years in the groups receiving and not receiving pirfenidone, respectively. The incidence of lung cancer was significantly higher in the pirfenidone group compared to non-users [2.44 vs. 1.56 per 100 person-years; risk ratio 1.56; 95% confidence interval (CI), 1.27-1.92]. However, the risk of mortality did not differ significantly between patients receiving pirfenidone and those who did not. Further analysis was conducted to assess lung cancer development and pirfenidone therapy. Among patients with lung cancer, those treated with pirfenidone demonstrated significantly improved survival compared to those not receiving pirfenidone therapy (log-rank test, P<0.001). Pirfenidone therapy was associated with a protective effect on mortality in IPF patients with lung cancer [hazard ratio, 0.61; 95% CI, 0.43-0.85].

Conclusions: Antifibrotic therapy was associated with improved survival in patients with IPF who develop lung cancer, even though the incidence of lung cancer was higher in those receiving antifibrotic treatment compared to those do not.

背景:特发性肺纤维化(IPF)患者有发展为肺癌的危险。抗纤维化治疗可以减缓IPF的疾病进展,但关于其对肺癌的有效性的数据有限。在这里,我们的目的是调查接受抗纤维化治疗的IPF患者的肺癌发病率和死亡风险。方法:使用2015年10月至2021年9月韩国国民健康保险服务数据库中的数据。根据吡非尼酮治疗对IPF队列中肺癌发病率和全因死亡率进行分析。那些在IPF诊断前被诊断为肺癌的患者被排除在外。结果:在5038名符合研究条件的IPF患者中,有880名患者接受了吡非尼酮治疗。接受吡非尼酮治疗组和未接受吡非尼酮治疗组的中位随访时间分别为4872.8人和23612.1人年。吡非尼酮组的肺癌发病率明显高于非使用者[2.44 vs 1.56 / 100人年;风险比1.56;95%置信区间(CI), 1.27-1.92]。然而,在接受吡非尼酮治疗的患者和未接受吡非尼酮治疗的患者之间,死亡风险没有显著差异。进一步分析评估肺癌发展和吡非尼酮治疗。在肺癌患者中,与未接受吡非尼酮治疗的患者相比,接受吡非尼酮治疗的患者的生存率显着提高(log-rank检验,p)结论:抗纤维化治疗与发展为肺癌的IPF患者的生存率改善相关,尽管接受抗纤维化治疗的患者的肺癌发病率高于未接受抗纤维化治疗的患者。
{"title":"Impact of antifibrotic therapy on lung cancer incidence and mortality in patients with idiopathic pulmonary fibrosis.","authors":"Yong Suk Jo, Kyung Joo Kim, Chin Kook Rhee, Yong Hyun Kim","doi":"10.21037/jtd-24-1356","DOIUrl":"https://doi.org/10.21037/jtd-24-1356","url":null,"abstract":"<p><strong>Background: </strong>Patients with idiopathic pulmonary fibrosis (IPF) are at risk of lung cancer development. Antifibrotic therapy could slow disease progression of IPF, but there is limited data on its effectiveness on lung cancer. Here, we aimed to investigate lung cancer incidence and the risk of mortality of patients with IPF receiving antifibrotic therapy.</p><p><strong>Methods: </strong>Data from the Korean National Health Insurance service database between October 2015 and September 2021 were used. The incidence of lung cancer and all-cause mortality in the IPF cohort was analyzed depending on pirfenidone treatment. Those who were diagnosed with lung cancer prior to IPF diagnosis were excluded.</p><p><strong>Results: </strong>Among the 5,038 patients with IPF who were eligible for the study, pirfenidone was administered to 880 patients. Median follow-up duration was 4,872.8 and 23,612.1 person-years in the groups receiving and not receiving pirfenidone, respectively. The incidence of lung cancer was significantly higher in the pirfenidone group compared to non-users [2.44 <i>vs.</i> 1.56 per 100 person-years; risk ratio 1.56; 95% confidence interval (CI), 1.27-1.92]. However, the risk of mortality did not differ significantly between patients receiving pirfenidone and those who did not. Further analysis was conducted to assess lung cancer development and pirfenidone therapy. Among patients with lung cancer, those treated with pirfenidone demonstrated significantly improved survival compared to those not receiving pirfenidone therapy (log-rank test, P<0.001). Pirfenidone therapy was associated with a protective effect on mortality in IPF patients with lung cancer [hazard ratio, 0.61; 95% CI, 0.43-0.85].</p><p><strong>Conclusions: </strong>Antifibrotic therapy was associated with improved survival in patients with IPF who develop lung cancer, even though the incidence of lung cancer was higher in those receiving antifibrotic treatment compared to those do not.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8528-8537"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The biomechanical effect of the O-A angle on the aortic valve under left ventricular assist device support: a primary fluid-structure interaction study. 左心室辅助装置支持下O-A角对主动脉瓣的生物力学影响:一项初步的流体-结构相互作用研究
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-28 DOI: 10.21037/jtd-24-1650
Weining Wang, Xiaoyu Ren, Qinxin Xue, Hussein Sliman, Bin Gao, Shu Li, Yu Chang, Youjun Liu

Background: Left ventricular assist device (LVAD) has been widely used as an alternative treatment for heart failure, however, aortic regurgitation is a common complication in patients with LVAD support. And the O-A angle (the angle between LVAD outflow graft and the aorta) is considered as a vital factor associated with the function of aortic valve. To date, the biomechanical effect of the O-A angle on the aortic valve remains largely unknown. The aim of this study was to evaluate the O-A angle how to influence the aortic valve biomechanical properties.

Methods: The current study employed a novel fluid-structure interaction (FSI) model that integrates the Lattice Boltzmann method (LBM) and the finite element method (FEM) to investigate the biomechanical effect of the O-A angle on the aortic valve under LVAD support. The biomechanical status of the aortic valve was evaluated at three different O-A angles (45, 90 and 135 degrees) and. four indicators, including stress distribution, the mean stress, the axial hemodynamic force (AHF) and the wall shear stress (WSS) distribution were evaluated at three timepoints (28, 133, and 266 ms).

Results: The results showed that the stress and the high-stress region on the aortic leaflets increased as the O-A angle increased and as the difference between the left ventricular pressure (LVP) and aortic pressure (AP) increased. And the aortic insufficiency was observed at the 28 ms (systolic phase) in the 135-degree O-A angle. During the systolic phase, significant fluctuation in the mean stress was observed when the O-A angle was 90 or 135 degrees. During the diastolic phase, the mean stress increased in the three O-A angle conditions when the difference between the LVP and AP increased. Regarding to the AHF, an obvious fluctuation was observed during the systolic phase (0-100 ms) in the 135-degree O-A angle. During the diastolic phase, the AHF increased in the three O-A angle conditions when the difference between the LVP and AP increased. For the WSS distribution evaluation, the WSS was increased when the O-A angle increased. At 28 ms (the systolic phase), a high WSS was located on the free edge of the leaflets, and the deformed leaflets were observed in the 135-degree O-A angle. And at 133 ms (the rapid diastolic phase), a high WSS was observed at the free edge of the leaflets when the O-A angles were 45 or 90 degrees, and at both free edge and belly of the leaflets in the 135-degree O-A angle.

Conclusions: The O-A angle is closely associated with the biomechanical status of the aortic valve under LVAD support. A large O-A angle caused high stress and WSS on the aortic leaflets, as well as broad stress and WSS distribution, thus leading to deformed leaflets and retrograde flow. Therefore, optimization of the O-A angle will favor to maintain aortic valve function.

背景:左心室辅助装置(LVAD)已被广泛用作心力衰竭的替代治疗方法,然而,主动脉瓣反流是LVAD支持患者的常见并发症。而O-A角(LVAD流出段移植物与主动脉之间的夹角)被认为是影响主动脉瓣功能的重要因素。到目前为止,O-A角对主动脉瓣的生物力学影响仍然很大程度上未知。本研究旨在探讨O-A角对主动脉瓣生物力学性能的影响。方法:本研究采用一种结合Lattice Boltzmann法(LBM)和有限元法(FEM)的新型流固耦合(FSI)模型,研究LVAD支持下O-A角对主动脉瓣的生物力学影响。在三个不同的O-A角度(45度,90度和135度)评估主动脉瓣的生物力学状态。在28,133和266ms三个时间点评估应力分布、平均应力、轴向血流动力(AHF)和壁面剪切应力(WSS)分布等4项指标。结果:随着O-A角的增大和左室压(LVP)与主动脉压(AP)差值的增大,主动脉小叶上的应力和高应力区增大。在135°O-A角的28 ms(收缩期)观察到主动脉供血不足。在收缩期,当O-A角为90°或135°时,观察到平均应力的显著波动。在舒张期,三种O-A角条件下的平均应力随LVP和AP差的增大而增大。在135°O-A角的收缩期(0 ~ 100 ms), AHF有明显波动。在舒张期,三种O-A角条件下,随着LVP和AP差的增加,AHF增加。对于WSS分布评价,WSS随O-A角的增大而增大。收缩期28 ms时,小叶自由边缘出现高WSS, 135°O-A角可见变形小叶。在快速舒张期133 ms时,当O-A角为45°和90°时,小叶自由边缘和135°O-A角时,小叶自由边缘和腹部均出现高WSS。结论:主动脉瓣O-A角与LVAD支持下主动脉瓣的生物力学状态密切相关。大O-A角导致主动脉小叶应力和WSS高,应力和WSS分布宽,导致小叶变形和逆行血流。因此,优化O-A角有利于维持主动脉瓣功能。
{"title":"The biomechanical effect of the O-A angle on the aortic valve under left ventricular assist device support: a primary fluid-structure interaction study.","authors":"Weining Wang, Xiaoyu Ren, Qinxin Xue, Hussein Sliman, Bin Gao, Shu Li, Yu Chang, Youjun Liu","doi":"10.21037/jtd-24-1650","DOIUrl":"https://doi.org/10.21037/jtd-24-1650","url":null,"abstract":"<p><strong>Background: </strong>Left ventricular assist device (LVAD) has been widely used as an alternative treatment for heart failure, however, aortic regurgitation is a common complication in patients with LVAD support. And the O-A angle (the angle between LVAD outflow graft and the aorta) is considered as a vital factor associated with the function of aortic valve. To date, the biomechanical effect of the O-A angle on the aortic valve remains largely unknown. The aim of this study was to evaluate the O-A angle how to influence the aortic valve biomechanical properties.</p><p><strong>Methods: </strong>The current study employed a novel fluid-structure interaction (FSI) model that integrates the Lattice Boltzmann method (LBM) and the finite element method (FEM) to investigate the biomechanical effect of the O-A angle on the aortic valve under LVAD support. The biomechanical status of the aortic valve was evaluated at three different O-A angles (45, 90 and 135 degrees) and. four indicators, including stress distribution, the mean stress, the axial hemodynamic force (AHF) and the wall shear stress (WSS) distribution were evaluated at three timepoints (28, 133, and 266 ms).</p><p><strong>Results: </strong>The results showed that the stress and the high-stress region on the aortic leaflets increased as the O-A angle increased and as the difference between the left ventricular pressure (LVP) and aortic pressure (AP) increased. And the aortic insufficiency was observed at the 28 ms (systolic phase) in the 135-degree O-A angle. During the systolic phase, significant fluctuation in the mean stress was observed when the O-A angle was 90 or 135 degrees. During the diastolic phase, the mean stress increased in the three O-A angle conditions when the difference between the LVP and AP increased. Regarding to the AHF, an obvious fluctuation was observed during the systolic phase (0-100 ms) in the 135-degree O-A angle. During the diastolic phase, the AHF increased in the three O-A angle conditions when the difference between the LVP and AP increased. For the WSS distribution evaluation, the WSS was increased when the O-A angle increased. At 28 ms (the systolic phase), a high WSS was located on the free edge of the leaflets, and the deformed leaflets were observed in the 135-degree O-A angle. And at 133 ms (the rapid diastolic phase), a high WSS was observed at the free edge of the leaflets when the O-A angles were 45 or 90 degrees, and at both free edge and belly of the leaflets in the 135-degree O-A angle.</p><p><strong>Conclusions: </strong>The O-A angle is closely associated with the biomechanical status of the aortic valve under LVAD support. A large O-A angle caused high stress and WSS on the aortic leaflets, as well as broad stress and WSS distribution, thus leading to deformed leaflets and retrograde flow. Therefore, optimization of the O-A angle will favor to maintain aortic valve function.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8620-8632"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic analysis of acute type A aortic dissection after different surgical interventions: a cohort study. 不同手术干预后急性A型主动脉夹层的预后分析:一项队列研究。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-31 Epub Date: 2024-12-28 DOI: 10.21037/jtd-2024-2048
Qi-Yuan Zhu, Xiao-Shuo Lv, Shou-Ming Li, Xiao-Nan Li, Wei Zhang, Jin-Rong Xue, Zuo Zhang, Mikko Uimonen, Ari Mennander, Hong-Lei Zhao

Background: Acute type A aortic dissection (ATAAD) requires emergency surgery, but the choice of primary surgery remains controversial. It is believed that simple ascending aorta replacement may lead to higher postoperative survival rate, while the Sun procedure [frozen elephant trunk (FET) + total arch replacement (TAR)] performed in the first stage may obtain better long-term results. The study aimed to compare the outcome of ATAAD patients who underwent the Sun procedure with those without TAR + FET.

Methods: Data of 452 patients with ATAAD admitted to Beijing Anzhen Hospital for surgical treatment from August 1, 2020, to August 16, 2022, were collected and analyzed. Patients with the Sun procedure (n=344) were compared to those without the Sun procedure (n=108). The two groups of patients were matched using propensity score matching (PSM), and the risk factors of poor prognosis were analyzed.

Results: The average postoperative follow-up period was 976±414 days, and the loss of follow-up rate was 0. The postoperative 30-day mortality rates were 12.56% and 5.38% in the Sun procedure group and the non-Sun procedure group after PSM matching, respectively (P=0.06). Multivariate logistic regression analysis showed that postoperative cardiogenic shock, postoperative cerebral malperfusion syndrome (MPS), postoperative spinal MPS, and need for continuous renal replacement therapy (CRRT) were independent risk factors for postoperative 30-day death. The 3-year survival rates were 85.02% and 91.40% in the Sun procedure group and the non-Sun procedure group after PSM matching, respectively (P=0.12). According to multivariate cox regression analysis, the independent risk factors associated with postoperative midterm death were consistent with those associated with 30-day postoperative death that pointed out by logistic regression. The incidence of spinal MPS after the Sun procedure was higher than that in the non-Sun procedure group (P=0.003). At 3-year follow-up, the probability of no distal aortic events (DAEs) was 97.17% and 91.59%, in the Sun procedure group and non-Sun procedure group, respectively, representing a significant difference (P=0.02). Multivariate Cox regression showed that Marfan syndrome and non-Sun procedure were risk factors for DAEs. Fine-Gray analysis also produced results similar to multifactor cox regression analysis, that Marfan syndrome and non-Sun procedure were risk factors for DAEs.

Conclusions: There was no significant difference in postoperative mortality between the Sun procedure group and the non-Sun procedure group. The incidence of spinal MPS in the Sun procedure group was higher than that in the non-Sun procedure group, while the incidence of DAEs in the Sun procedure group was lower than that in non-Sun procedure group.

背景:急性A型主动脉夹层(ATAAD)需要紧急手术治疗,但首选手术仍有争议。单纯升主动脉置换术可提高术后生存率,而一期行Sun手术[冷冻象鼻(FET) +全弓置换术(TAR)]可获得较好的远期疗效。该研究旨在比较接受Sun手术的ATAAD患者与未接受TAR + FET的患者的结果。方法:收集2020年8月1日至2022年8月16日在北京安贞医院接受手术治疗的452例ATAAD患者资料并进行分析。接受Sun手术的患者(n=344)与未接受Sun手术的患者(n=108)进行比较。采用倾向评分匹配法(PSM)对两组患者进行匹配,分析两组患者预后不良的危险因素。结果:术后平均随访时间为976±414天,失访率为0。PSM匹配后,太阳手术组和非太阳手术组的术后30天死亡率分别为12.56%和5.38% (P=0.06)。多因素logistic回归分析显示,术后心源性休克、术后脑灌注不良综合征(MPS)、术后脊柱MPS和是否需要持续肾替代治疗(CRRT)是术后30天死亡的独立危险因素。PSM配对后,Sun手术组和非Sun手术组的3年生存率分别为85.02%和91.40% (P=0.12)。多因素cox回归分析显示,与术后中期死亡相关的独立危险因素与经logistic回归分析指出的术后30天死亡相关的独立危险因素一致。太阳手术后脊髓MPS的发生率高于非太阳手术组(P=0.003)。3年随访时,Sun手术组和非Sun手术组无远端主动脉事件(DAEs)的概率分别为97.17%和91.59%,差异有统计学意义(P=0.02)。多因素Cox回归分析显示马凡氏综合征和非sun手术是DAEs的危险因素。Fine-Gray分析也产生了与多因素cox回归分析相似的结果,马凡氏综合征和非sun手术是DAEs的危险因素。结论:太阳手术组与非太阳手术组的术后死亡率无显著差异。太阳手术组脊柱MPS的发生率高于非太阳手术组,而太阳手术组DAEs的发生率低于非太阳手术组。
{"title":"Prognostic analysis of acute type A aortic dissection after different surgical interventions: a cohort study.","authors":"Qi-Yuan Zhu, Xiao-Shuo Lv, Shou-Ming Li, Xiao-Nan Li, Wei Zhang, Jin-Rong Xue, Zuo Zhang, Mikko Uimonen, Ari Mennander, Hong-Lei Zhao","doi":"10.21037/jtd-2024-2048","DOIUrl":"https://doi.org/10.21037/jtd-2024-2048","url":null,"abstract":"<p><strong>Background: </strong>Acute type A aortic dissection (ATAAD) requires emergency surgery, but the choice of primary surgery remains controversial. It is believed that simple ascending aorta replacement may lead to higher postoperative survival rate, while the Sun procedure [frozen elephant trunk (FET) + total arch replacement (TAR)] performed in the first stage may obtain better long-term results. The study aimed to compare the outcome of ATAAD patients who underwent the Sun procedure with those without TAR + FET.</p><p><strong>Methods: </strong>Data of 452 patients with ATAAD admitted to Beijing Anzhen Hospital for surgical treatment from August 1, 2020, to August 16, 2022, were collected and analyzed. Patients with the Sun procedure (n=344) were compared to those without the Sun procedure (n=108). The two groups of patients were matched using propensity score matching (PSM), and the risk factors of poor prognosis were analyzed.</p><p><strong>Results: </strong>The average postoperative follow-up period was 976±414 days, and the loss of follow-up rate was 0. The postoperative 30-day mortality rates were 12.56% and 5.38% in the Sun procedure group and the non-Sun procedure group after PSM matching, respectively (P=0.06). Multivariate logistic regression analysis showed that postoperative cardiogenic shock, postoperative cerebral malperfusion syndrome (MPS), postoperative spinal MPS, and need for continuous renal replacement therapy (CRRT) were independent risk factors for postoperative 30-day death. The 3-year survival rates were 85.02% and 91.40% in the Sun procedure group and the non-Sun procedure group after PSM matching, respectively (P=0.12). According to multivariate cox regression analysis, the independent risk factors associated with postoperative midterm death were consistent with those associated with 30-day postoperative death that pointed out by logistic regression. The incidence of spinal MPS after the Sun procedure was higher than that in the non-Sun procedure group (P=0.003). At 3-year follow-up, the probability of no distal aortic events (DAEs) was 97.17% and 91.59%, in the Sun procedure group and non-Sun procedure group, respectively, representing a significant difference (P=0.02). Multivariate Cox regression showed that Marfan syndrome and non-Sun procedure were risk factors for DAEs. Fine-Gray analysis also produced results similar to multifactor cox regression analysis, that Marfan syndrome and non-Sun procedure were risk factors for DAEs.</p><p><strong>Conclusions: </strong>There was no significant difference in postoperative mortality between the Sun procedure group and the non-Sun procedure group. The incidence of spinal MPS in the Sun procedure group was higher than that in the non-Sun procedure group, while the incidence of DAEs in the Sun procedure group was lower than that in non-Sun procedure group.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8709-8723"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of thoracic disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1